Read more
Biotechnology is one of the most promising fields of technology, especially since molecular biology methods have enhanced our knowledge of genes, their structure, and their action. This knowledge makes it possible to change genetic material and construct new varieties of cultural plants and animals for various purposes such as nutrition, scientific and medical experimentation, and treatment of human diseases. Such inventions may even include human genes. The understandable desire to have legal protection in this domain has created new problems - especially from the viewpoint of the law and acquiring patents for these new inventions. These problems are under wide discussion and are often controversial. This volume provides a unique overview of the current problems and opinions in this controversial field.
List of contents
Session 1.- Begrüßung.- Welcoming Adress.- Patenting of Human Genes and Living Organisms - A Nightmare for the Scientist.- Patenting of Human Genes and Living Organisms - The Legal Situation in Europe.- Remarks on "Technology Transfer and the Genome Program".- Session 2.- Intellectual Property in the Field of Life Sciences.- Session 3.- Legal Protection of Living Organisms from the Point of View of Scientists in Animal Breeding.- Legal Protection of Living Organisms from the Point of View of Scientists in Plant Breeding.- "Patenting" of Living Organisms - Patents and Plant Breeders' Rights - From the Point of View of Plant Breeders.- Genetic Diversity and the Indian Seed Industry.- Patenting Living Organisms and Their Parts: The Point of View of Science Administration.- Patenting of Human Genes and Living Organisms - The Current Practice of the European Patent Office.- Session 4.- Patenting of Human Genes and Living Organisms: An Ethical Point of View.- Session 5.- The Patenting of Genes and Living Organisms: The South's View.- Patenting of Human Genes and Living Organisms: The Socio-Political Situation in the United States of America.- Session 6.- The Human Renin-Angiotensin-System in Transgenic Rats.- Which Rules of Patenting are Acceptable from the Point of View of Industry?.- Patentability of Human Genes and Living Organisms: Principles of a Possible International Understanding.- What does Pharmaceutical Industry expect of Patenting Human Genes and Living Organisms?.- Round Table Discussion.
About the author
Friedrich Vogel studierte Rechtswissenschaft und Betriebswirtschaftslehre an den Universitäten in München, Bonn und Köln (Diplom Kaufmann). 1966 Promotion zum Dr. rer. pol.; 1974 Habilitation, venia legendi für "Statistik"; Ernennung zum Privatdozenten für Statistik an der Universität zu Köln; 1975 Ernennung zum Professor für Statistik an der Christian-Albrechts-Universität Kiel; 1978 Ernennung zum ordentlichen Professor für Statistik an derOtto-Friedrich-Universität Bamberg. Emeritierung im März 2006.§Zahlreiche Veröffentlichungen zu verschiedenen Gebieten der Statistik, insbesondere zur Numerischen Klassifikation, zu deskriptiven und induktiven Methoden, zur Verarbeitung nominaler und ordinaler Merkmale sowie zu Messung von Zusammenhängen nicht-metrischer Merkmale.
Summary
The recent results of biological research (molecular biology; plant and animal breeding) - and attempts at getting such results patented - have led to new problems that need to be discussed from the points of view of fields such as biology, medicine, law, and ethics. The contributions and discussions published in this volume may help to clarify these issues.
Additional text
"I recommend this book to all scientists concerned about the issues of IPR; ...it gives valuable information in an important and fast-moving field that cannot be gained elsewhere." - Genetical Research
Report
"I recommend this book to all scientists concerned about the issues of IPR; ...it gives valuable information in an important and fast-moving field that cannot be gained elsewhere." - Genetical Research
